Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Dowling

Showing results (141-150 of 163) with videos related to

Pageof 17
Sort By:
Cancer Treatment Reports|December 1, 1982
Phase I trial of Staphylococcus aureus Cowan I immunoperfusionG Messerschmidt, C Bowles, D Dean, et al.
British Journal of Pharmacology|March 20, 2014
Investigating the molecular mechanisms through which FTY720-P causes persistent S1P1 receptor internalizationDavid A Sykes, Darren M Riddy, Craig Stamp, et al.
Blood Advances|April 3, 2020
Germline heterozygous mutations in Nxf1 perturb RNA metabolism and trigger thrombocytopenia and lymphopenia in miceStéphane Chappaz, Charity W Law, Mark R Dowling, et al.
Transplantation and Cellular Therapy|May 30, 2026
A critical review of clinical factors and tools for predicting chimeric antigen receptor T-cell toxicitiesJian Li, Mark R Dowling, Miriam Wronski, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 26, 2006
In vitro and in vivo pharmacological characterization of 5-[(R)-2-(5,6-diethyl-indan-2-ylamino)-1-hydroxy-ethyl]-8-hydroxy-1H-quinolin-2-one (indacaterol), a novel inhaled beta(2) adrenoceptor agonist with a 24-h duration of actionCliff Battram, Steven J Charlton, Bernard Cuenoud, et al.
Science Immunology|October 28, 2022
Long-lived plasma cells accumulate in the bone marrow at a constant rate from early in an immune responseMarcus James Robinson, Mark R Dowling, Catherine Pitt, et al.
Scientific Reports|February 24, 2023
Experimental venous thrombus resolution is driven by IL-6 mediated monocyte actionsAndrea T Obi, Sriganesh B Sharma, Megan A Elfline, et al.
Thrombosis and Haemostasis|December 31, 2019
Ly6CLo Monocyte/Macrophages are Essential for Thrombus Resolution in a Murine Model of Venous ThrombosisAndrew Scott Kimball, Andrea Tara Obi, Catherine E Luke, et al.
Immunity|May 10, 2023
Intrinsically determined turnover underlies broad heterogeneity in plasma-cell lifespanMarcus James Robinson, Zhoujie Ding, Mark R Dowling, et al.
Frontiers in Immunology|July 25, 2022
NKG7 Enhances CD8+ T Cell Synapse Efficiency to Limit InflammationEmily J Lelliott, Kelly M Ramsbottom, Mark R Dowling, et al.
Pageof 17

Showing results (141-150 of 163) with videos related to

Sort By:
Pageof 17
Cancer Treatment Reports|December 1, 1982
Phase I trial of Staphylococcus aureus Cowan I immunoperfusionG Messerschmidt, C Bowles, D Dean, et al.
British Journal of Pharmacology|March 20, 2014
Investigating the molecular mechanisms through which FTY720-P causes persistent S1P1 receptor internalizationDavid A Sykes, Darren M Riddy, Craig Stamp, et al.
Blood Advances|April 3, 2020
Germline heterozygous mutations in Nxf1 perturb RNA metabolism and trigger thrombocytopenia and lymphopenia in miceStéphane Chappaz, Charity W Law, Mark R Dowling, et al.
Transplantation and Cellular Therapy|May 30, 2026
A critical review of clinical factors and tools for predicting chimeric antigen receptor T-cell toxicitiesJian Li, Mark R Dowling, Miriam Wronski, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 26, 2006
In vitro and in vivo pharmacological characterization of 5-[(R)-2-(5,6-diethyl-indan-2-ylamino)-1-hydroxy-ethyl]-8-hydroxy-1H-quinolin-2-one (indacaterol), a novel inhaled beta(2) adrenoceptor agonist with a 24-h duration of actionCliff Battram, Steven J Charlton, Bernard Cuenoud, et al.
Science Immunology|October 28, 2022
Long-lived plasma cells accumulate in the bone marrow at a constant rate from early in an immune responseMarcus James Robinson, Mark R Dowling, Catherine Pitt, et al.
Scientific Reports|February 24, 2023
Experimental venous thrombus resolution is driven by IL-6 mediated monocyte actionsAndrea T Obi, Sriganesh B Sharma, Megan A Elfline, et al.
Thrombosis and Haemostasis|December 31, 2019
Ly6CLo Monocyte/Macrophages are Essential for Thrombus Resolution in a Murine Model of Venous ThrombosisAndrew Scott Kimball, Andrea Tara Obi, Catherine E Luke, et al.
Immunity|May 10, 2023
Intrinsically determined turnover underlies broad heterogeneity in plasma-cell lifespanMarcus James Robinson, Zhoujie Ding, Mark R Dowling, et al.
Frontiers in Immunology|July 25, 2022
NKG7 Enhances CD8+ T Cell Synapse Efficiency to Limit InflammationEmily J Lelliott, Kelly M Ramsbottom, Mark R Dowling, et al.
Pageof 17